-leukin
Versions of interleukin-2.
- Drugs ending in -leukin: 12
- Approved somewhere: 2
- With a US drug page: 1
- Stem
- -leukin
- Class
- Versions of interleukin-2
- Sub-stem of
- -kin: Interleukins and similar immune signalling proteins
- Most common targets
- Interleukin-2 receptor (2), EEF2 (1), IL2RB, IL2RG (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -leukin, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Aldesleukin | Approved | Interleukin-2 receptor | Interleukin-2 receptor agonist |
| Denileukin diftitox | Approved | EEF2, Interleukin-2 receptor | Elongation factor 2 inhibitor |
| Bempegaldesleukin | Phase 3 | — | — |
| Efavaleukin alfa | Phase 2 | — | — |
| Efercoleukin alfa | Phase 2 | — | — |
| Interleukin 15, recombinant non-glycosylated | Phase 2 | — | — |
| Onvapegleukin alfa | Phase 2 | — | — |
| Pegenzileukin | Phase 2 | IL2RB, IL2RG | IL-2R beta/gamma agonist |
| Rezpegaldesleukin | Phase 2 | — | — |
| Darleukin | Phase 1 | — | — |
| Melredableukin alfa | Phase 1 | — | — |
| Nemvaleukin alfa | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO